from The American Heritage® Dictionary of the English Language, 4th Edition
- n. A white, odorless, tasteless crystalline ester, C6H4NH2CO2C2H5, used as a local anesthetic.
from Wiktionary, Creative Commons Attribution/Share-Alike License
- n. A local anesthetic commonly used as a topical pain reliever.
from the GNU version of the Collaborative International Dictionary of English
- n. a chemical substance obtainable as a white crystalline ester (H2N.C6H4.CO.O.C2H5) used as a local anesthetic. Chemically, it is 4-aminobenzoic acid ethyl ester.
from WordNet 3.0 Copyright 2006 by Princeton University. All rights reserved.
- n. a white crystalline ester used as a local anesthetic
Sorry, no etymologies found.
- Health Canada suggest avoiding creams or lotions that may hold heat inside the skin or may contain numbing medication (such as benzocaine or lidocaine).
The substances - such as benzocaine and lidocaine - are legal and imported from countries like China.
More powerful formulations, with a stronger concentration of anaesthetic ingredients such as benzocaine, are available only from the pharmacy counter because of possible allergic reactions.
If available, apply an antiseptic medicine containing benzocaine to the affected area.
Athletic performance and had benziq by three benzocaine would do places.
I can do without that awesome Kiehl's body wash, the shaving cream with benzocaine in it, sugar cereals, those linen shirts I've been craving, Coke, American Crew Fiber hair stuff, the cell phone, Chelsea Piers and tuna.
With designersigned T-shirts and Parisian jeans; forty-dollar sunglasses; the smell of benzocaine, camphor, hot burning flesh.
Health Canada says topical benzocaine products are available over-the-counter in a variety of formulations, including sprays, gels, liquids and creams.
Other reported side-effects associated with topical benzocaine products include breathing or swallowing difficulties, a swollen tongue or mouth, irregular heartbeat, malaise, body twitching, hypersensitivity, burning, redness, itching, rash and irritation at the site of administration.
The agency says it first issued an advisory about the risk of methomoglobinemia, or MetHb, in November 2006, and has since received seven reports of serious adverse reactions linked to topical benzocaine - including four reports of MetHb.